Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01560377 · ClinicalTrials.gov registry record · Phase 1
Perfusion Assessment in Laparoscopic Left Anterior Resection
A Phase 1 study, sponsored by Novadaq Technologies ULC, now a part of Stryker.
- Completed
- Registry status
- Phase 1
- Development phase
- 147
- Enrollment target
NCT01560377 is a Phase 1 study that has completed, run by Novadaq Technologies ULC, now a part of Stryker. The registered enrollment target is 147 participants.
The verdict
NCT01560377, a Phase 1 study, has completed, sponsored by Novadaq Technologies ULC, now a part of Stryker.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 147 participants
- Enrollment target
Study Summary
The purpose of this study is to demonstrate that NIR fluorescence angiography using the PINPOINT Endoscopic Fluorescence Imaging System ("PINPOINT System" or "PINPOINT") can assess viability of colon tissue during laparoscopic left colectomy. This information will provide the surgeon with clinically relevant information in assessing whether or not the tissue has adequate blood supply in the lower section of the colon prior to a colectomy.
Interventions
- DEVICE PINPOINT Endoscopic Fluorescence Imaging System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 147 participants |
| Start Date | 2012-05 |
| Est. Completion | 2013-11 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01560377
The ClinicalTrials.gov registry entry for NCT01560377 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 147 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Novadaq Technologies ULC, now a part of Stryker, which has 4 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which PINPOINT Endoscopic Fluorescence Imaging System is the first listed.
NCT01560377 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01560377 about?
NCT01560377 is a clinical study titled "Perfusion Assessment in Laparoscopic Left Anterior Resection". The purpose of this study is to demonstrate that NIR fluorescence angiography using the PINPOINT Endoscopic Fluorescence Imaging System ("PINPOINT System" or "PINPOINT") can assess viability of colon tissue during laparoscopic left colectomy. This information will provide the surgeon with clinically...
What is the current status of trial NCT01560377?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 147 participants. The study started on 2012-05. Estimated completion is 2013-11.
What interventions are being tested in trial NCT01560377?
The interventions under investigation include: PINPOINT Endoscopic Fluorescence Imaging System (DEVICE).
Who is sponsoring clinical trial NCT01560377?
This trial is sponsored by Novadaq Technologies ULC, now a part of Stryker, which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.